简单易懂,事半功倍。
提高接受率,人人国自然!

Call for paper: Front Oncol (IF4.137) and Front Genet (IF3.517)

https://www.frontiersin.org/research-topics/10686/the-role-of-ncrnas-in-solid-tumors-prognosis-from-laboratory-to-clinical-utility

Research Topic

The Role of ncRNAs in Solid Tumors Prognosis: From Laboratory To Clinical Utility

About this Research Topic

Noncoding RNAs (ncRNAs) are involved in the regulation of various cell processes, including transcription, intracellular trafficking, and chromosome remodeling. Their dysregulation has been associated with the development and progression of various types of cancers, which makes them promising cancer biomarkers. In recent years, the detection of cancer-associated ncRNAs in body fluids of cancer patients has proven itself as a particularly valuable method to effectively diagnose cancer. Cancer prognosis employing circulating ncRNAs is preferential when compared to traditional tumor tissue biopsies, especially due to their noninvasiveness, and have great potential for routine application in clinical practice. Thus, this article collection focuses on summarizing the perspectives of ncRNAs as biomarkers in cancer, based on evaluating their expression profiles determined in body fluids of cancer patients.

The stability of ncRNAs in body fluids of cancer patients has not been thoroughly explored. Although several studies have demonstrated that ncRNAs, unlike lncRNAs, are highly stable under diverse temperature and storage conditions, our understanding of the former is still at the initial stages, especially for the more recently detected ncRNAs such as microRNA, lncRNAs, piRNAs, and circRNAs.

In this Research Topic, we would like to present the recent advances on the roles of ncRNAs on tumorigenesis, metastasis, chemoresistance, radioresistance as well as their potential clinical applications in solid cancers. We welcome the submission of Original Research, Review and Systematic Review articles dedicated to:

1) The mechanisms of ncRNAs in cancer development and progression

2) Large scale analysis of ncRNAs

3) Identification and validation the ncRNA prognostic model for cancers by TCGA, GEO or original data

Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Submission Deadlines

04 August 2019 Abstract

02 December 2019 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Frontiers in Oncology

Frontiers in Genetics

除特别注明外,本站所有文章均为SCI666原创,转载请注明出处,谢谢。sci666 » Call for paper: Front Oncol (IF4.137) and Front Genet (IF3.517)

评论 抢沙发

  • QQ号
  • 昵称 (必填)
  • 邮箱 (必填)
  • 网址

SCI666 学习、交流、分享

meta、生信交流群综合科研交流群
切换注册

登录

忘记密码 ?

您也可以使用第三方帐号快捷登录

切换登录

注册

我们将发送一封验证邮件至你的邮箱, 请正确填写以完成账号注册和激活